Cargando…

A brief telephone-delivered peer intervention to encourage enrollment in medication for opioid use disorder in individuals surviving an opioid overdose: Results from a randomized pilot trial

BACKGROUND: Medication for opioid use disorder (MOUD) can decrease the risk of opioid overdose (OOD) in individuals with opioid use disorder. Peer recovery support services (PRSS) are increasingly used to promote MOUD engagement but evidence of their efficacy is limited. This study’s objective was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Winhusen, Theresa, Wilder, Christine, Kropp, Frankie, Theobald, Jeff, Lyons, Michael S., Lewis, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462596/
https://www.ncbi.nlm.nih.gov/pubmed/32911132
http://dx.doi.org/10.1016/j.drugalcdep.2020.108270
_version_ 1783576951231873024
author Winhusen, Theresa
Wilder, Christine
Kropp, Frankie
Theobald, Jeff
Lyons, Michael S.
Lewis, Daniel
author_facet Winhusen, Theresa
Wilder, Christine
Kropp, Frankie
Theobald, Jeff
Lyons, Michael S.
Lewis, Daniel
author_sort Winhusen, Theresa
collection PubMed
description BACKGROUND: Medication for opioid use disorder (MOUD) can decrease the risk of opioid overdose (OOD) in individuals with opioid use disorder. Peer recovery support services (PRSS) are increasingly used to promote MOUD engagement but evidence of their efficacy is limited. This study’s objective was to evaluate a single 20-minute telephone-delivered PRSS intervention for increasing MOUD enrollment and decreasing recurring OODs. METHOD: This single-site, randomized controlled pilot trial enrolled adults, primarily recruited from a syringe service program, with an opioid-positive urine drug screen (UDS) reporting having been treated for an OOD within the past 6 months. Participants (N = 80) were randomized to PRSS (n = 40) or Control (n = 40) condition with all participants receiving personally-tailored OOD education and naloxone. Outcome measures obtained at 3 (n = 66), 6 (n = 58), and 12 (n = 44) months post-randomization included verified MOUD enrollment (primary), self-reported OOD, and opioid use assessed by self-report and UDS. RESULTS: Through 12-month follow-up, 32.5 % of PRSS, compared to 17.5 % of Control participants enrolled in MOUD (X(2) = 2.4, p = 0.12; odds ratio = 2.27 (0.79–6.49)). PRSS participants were significantly less likely to have experienced an OOD through 12-month follow-up (12.5 % of PRSS participants, 32.5 % of Control, p = 0.03). No significant treatment effect was found for opioid use through 12-month follow-up as measured by either opioid-positive UDSs or self-reported past month opioid use days. Based on self-report, PRSS had good acceptability for both the interventionists and participants. CONCLUSIONS: The results suggest that further development and testing of this PRSS telephone intervention to encourage MOUD enrollment and reduce OOD may be warranted.
format Online
Article
Text
id pubmed-7462596
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-74625962020-09-02 A brief telephone-delivered peer intervention to encourage enrollment in medication for opioid use disorder in individuals surviving an opioid overdose: Results from a randomized pilot trial Winhusen, Theresa Wilder, Christine Kropp, Frankie Theobald, Jeff Lyons, Michael S. Lewis, Daniel Drug Alcohol Depend Article BACKGROUND: Medication for opioid use disorder (MOUD) can decrease the risk of opioid overdose (OOD) in individuals with opioid use disorder. Peer recovery support services (PRSS) are increasingly used to promote MOUD engagement but evidence of their efficacy is limited. This study’s objective was to evaluate a single 20-minute telephone-delivered PRSS intervention for increasing MOUD enrollment and decreasing recurring OODs. METHOD: This single-site, randomized controlled pilot trial enrolled adults, primarily recruited from a syringe service program, with an opioid-positive urine drug screen (UDS) reporting having been treated for an OOD within the past 6 months. Participants (N = 80) were randomized to PRSS (n = 40) or Control (n = 40) condition with all participants receiving personally-tailored OOD education and naloxone. Outcome measures obtained at 3 (n = 66), 6 (n = 58), and 12 (n = 44) months post-randomization included verified MOUD enrollment (primary), self-reported OOD, and opioid use assessed by self-report and UDS. RESULTS: Through 12-month follow-up, 32.5 % of PRSS, compared to 17.5 % of Control participants enrolled in MOUD (X(2) = 2.4, p = 0.12; odds ratio = 2.27 (0.79–6.49)). PRSS participants were significantly less likely to have experienced an OOD through 12-month follow-up (12.5 % of PRSS participants, 32.5 % of Control, p = 0.03). No significant treatment effect was found for opioid use through 12-month follow-up as measured by either opioid-positive UDSs or self-reported past month opioid use days. Based on self-report, PRSS had good acceptability for both the interventionists and participants. CONCLUSIONS: The results suggest that further development and testing of this PRSS telephone intervention to encourage MOUD enrollment and reduce OOD may be warranted. Elsevier B.V. 2020-11-01 2020-09-01 /pmc/articles/PMC7462596/ /pubmed/32911132 http://dx.doi.org/10.1016/j.drugalcdep.2020.108270 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Winhusen, Theresa
Wilder, Christine
Kropp, Frankie
Theobald, Jeff
Lyons, Michael S.
Lewis, Daniel
A brief telephone-delivered peer intervention to encourage enrollment in medication for opioid use disorder in individuals surviving an opioid overdose: Results from a randomized pilot trial
title A brief telephone-delivered peer intervention to encourage enrollment in medication for opioid use disorder in individuals surviving an opioid overdose: Results from a randomized pilot trial
title_full A brief telephone-delivered peer intervention to encourage enrollment in medication for opioid use disorder in individuals surviving an opioid overdose: Results from a randomized pilot trial
title_fullStr A brief telephone-delivered peer intervention to encourage enrollment in medication for opioid use disorder in individuals surviving an opioid overdose: Results from a randomized pilot trial
title_full_unstemmed A brief telephone-delivered peer intervention to encourage enrollment in medication for opioid use disorder in individuals surviving an opioid overdose: Results from a randomized pilot trial
title_short A brief telephone-delivered peer intervention to encourage enrollment in medication for opioid use disorder in individuals surviving an opioid overdose: Results from a randomized pilot trial
title_sort brief telephone-delivered peer intervention to encourage enrollment in medication for opioid use disorder in individuals surviving an opioid overdose: results from a randomized pilot trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462596/
https://www.ncbi.nlm.nih.gov/pubmed/32911132
http://dx.doi.org/10.1016/j.drugalcdep.2020.108270
work_keys_str_mv AT winhusentheresa abrieftelephonedeliveredpeerinterventiontoencourageenrollmentinmedicationforopioidusedisorderinindividualssurvivinganopioidoverdoseresultsfromarandomizedpilottrial
AT wilderchristine abrieftelephonedeliveredpeerinterventiontoencourageenrollmentinmedicationforopioidusedisorderinindividualssurvivinganopioidoverdoseresultsfromarandomizedpilottrial
AT kroppfrankie abrieftelephonedeliveredpeerinterventiontoencourageenrollmentinmedicationforopioidusedisorderinindividualssurvivinganopioidoverdoseresultsfromarandomizedpilottrial
AT theobaldjeff abrieftelephonedeliveredpeerinterventiontoencourageenrollmentinmedicationforopioidusedisorderinindividualssurvivinganopioidoverdoseresultsfromarandomizedpilottrial
AT lyonsmichaels abrieftelephonedeliveredpeerinterventiontoencourageenrollmentinmedicationforopioidusedisorderinindividualssurvivinganopioidoverdoseresultsfromarandomizedpilottrial
AT lewisdaniel abrieftelephonedeliveredpeerinterventiontoencourageenrollmentinmedicationforopioidusedisorderinindividualssurvivinganopioidoverdoseresultsfromarandomizedpilottrial
AT winhusentheresa brieftelephonedeliveredpeerinterventiontoencourageenrollmentinmedicationforopioidusedisorderinindividualssurvivinganopioidoverdoseresultsfromarandomizedpilottrial
AT wilderchristine brieftelephonedeliveredpeerinterventiontoencourageenrollmentinmedicationforopioidusedisorderinindividualssurvivinganopioidoverdoseresultsfromarandomizedpilottrial
AT kroppfrankie brieftelephonedeliveredpeerinterventiontoencourageenrollmentinmedicationforopioidusedisorderinindividualssurvivinganopioidoverdoseresultsfromarandomizedpilottrial
AT theobaldjeff brieftelephonedeliveredpeerinterventiontoencourageenrollmentinmedicationforopioidusedisorderinindividualssurvivinganopioidoverdoseresultsfromarandomizedpilottrial
AT lyonsmichaels brieftelephonedeliveredpeerinterventiontoencourageenrollmentinmedicationforopioidusedisorderinindividualssurvivinganopioidoverdoseresultsfromarandomizedpilottrial
AT lewisdaniel brieftelephonedeliveredpeerinterventiontoencourageenrollmentinmedicationforopioidusedisorderinindividualssurvivinganopioidoverdoseresultsfromarandomizedpilottrial